WO2009129943A8 - Formulierung mit reduzierter hygroskopizität - Google Patents

Formulierung mit reduzierter hygroskopizität Download PDF

Info

Publication number
WO2009129943A8
WO2009129943A8 PCT/EP2009/002691 EP2009002691W WO2009129943A8 WO 2009129943 A8 WO2009129943 A8 WO 2009129943A8 EP 2009002691 W EP2009002691 W EP 2009002691W WO 2009129943 A8 WO2009129943 A8 WO 2009129943A8
Authority
WO
WIPO (PCT)
Prior art keywords
formulation
reduced hygroscopicity
hygroscopicity
reduced
hygroscopic
Prior art date
Application number
PCT/EP2009/002691
Other languages
English (en)
French (fr)
Other versions
WO2009129943A1 (de
Inventor
Jesko Zank
Martin Steinbeck
Guido Becker
Udo Van Stiphout
Original Assignee
Bayer Technology Services Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Technology Services Gmbh filed Critical Bayer Technology Services Gmbh
Priority to CN2009801142789A priority Critical patent/CN102014875B/zh
Priority to US12/934,286 priority patent/US20110021355A1/en
Priority to EP09735236A priority patent/EP2271319A1/de
Publication of WO2009129943A1 publication Critical patent/WO2009129943A1/de
Publication of WO2009129943A8 publication Critical patent/WO2009129943A8/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Abstract

Die Erfindung betrifft Formulierungen von hygroskopischen, festen Stoffen mit einer lipophilen Hüllschicht, sowie ein Verfahren zu deren Herstellung.
PCT/EP2009/002691 2008-04-24 2009-04-11 Formulierung mit reduzierter hygroskopizität WO2009129943A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN2009801142789A CN102014875B (zh) 2008-04-24 2009-04-11 吸湿性降低的制剂
US12/934,286 US20110021355A1 (en) 2008-04-24 2009-04-11 Formulation with reduced hygroscopicity
EP09735236A EP2271319A1 (de) 2008-04-24 2009-04-11 Formulierung mit reduzierter hygroskopizität

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008020701.2 2008-04-24
DE102008020701A DE102008020701A1 (de) 2008-04-24 2008-04-24 Formulierung mit reduzierter Hygroskopizität

Publications (2)

Publication Number Publication Date
WO2009129943A1 WO2009129943A1 (de) 2009-10-29
WO2009129943A8 true WO2009129943A8 (de) 2010-11-18

Family

ID=40984892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/002691 WO2009129943A1 (de) 2008-04-24 2009-04-11 Formulierung mit reduzierter hygroskopizität

Country Status (5)

Country Link
US (1) US20110021355A1 (de)
EP (1) EP2271319A1 (de)
CN (1) CN102014875B (de)
DE (1) DE102008020701A1 (de)
WO (1) WO2009129943A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103271895A (zh) * 2012-03-14 2013-09-04 南京先宇科技有限公司 一种稳定的含有羟苯磺酸钙的药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB505362A (en) * 1937-03-01 1939-05-08 Armour & Co Improvements in compositions of matter containing anti-hygroscopic agents and processes of preparing the same
US2702747A (en) * 1951-08-27 1955-02-22 Phillips Petroleum Co Noncaking fertilizers
AU2944700A (en) 1999-03-15 2000-10-04 Kaken Pharmaceutical Co., Ltd. Quickly disintegrating tablets and process for producing the same
US6878693B2 (en) * 2001-09-28 2005-04-12 Solubest Ltd. Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
EP1575563B1 (de) * 2002-12-19 2007-02-14 Pharmacia Corporation Nicht-hygroskopische formulierung, die einen hygroskopischen wirkstoff enthält
AR050615A1 (es) * 2004-08-27 2006-11-08 Novartis Ag Composiciones farmaceuticas para la administracion oral
WO2007019229A1 (en) * 2005-08-05 2007-02-15 3M Innovative Properties Company Compositions exhibiting improved flowability
PT1864677E (pt) * 2006-06-02 2008-03-13 Teva Pharma Formulação estável compreendendo um fármaco sensível à humidade e processo para a sua produção
WO2007142628A1 (en) 2006-06-02 2007-12-13 Teva Pharmaceutical Industries Ltd. Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Also Published As

Publication number Publication date
DE102008020701A1 (de) 2009-10-29
CN102014875A (zh) 2011-04-13
EP2271319A1 (de) 2011-01-12
WO2009129943A1 (de) 2009-10-29
CN102014875B (zh) 2013-07-24
US20110021355A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
WO2010141693A3 (en) Borinic compositions
WO2007093627A3 (de) Biozide zusammensetzung
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2012014076A3 (en) Liver organoid, uses thereof and culture method for obtaining them
WO2010040508A8 (en) Bispecific anti-vegf/anti-ang-2 antibodies
WO2010031720A3 (en) Novel antibody formulation
IL216171A (en) Lipidic Compound, Method for Preparing the Compound, Pharmaceutical and Lipid Preparations Containing Their Composition and Uses
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2009100995A3 (de) Lagerstabile produktsysteme für prämixformulierungen
BRPI1016132A2 (pt) composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
WO2009100275A3 (en) Compositions and devices
WO2008075205A3 (en) Improved process for the preparation of voriconazole
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2008006575A3 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
WO2011067236A3 (de) Raltegravir-polymorphe
WO2012067491A3 (en) Compositions comprising extracts obtained from oil palm based materials for providing anti -inflammatory effects and method of producing thereof
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2010061935A3 (en) Composition and method for controlling plant diseases
AP2010005386A0 (en) Stabilized malathion microcapsule formulations.
WO2011146390A3 (en) Compositions and methods for in vivo imaging
WO2010018441A3 (en) Process for the preparation of substantially pure telmisartan
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
EP2634183B8 (de) Verfahren zur herstellung von 1,3,5-trioxan
WO2012134103A3 (ko) 노보넨 에스터계 유도체, 이의 제조방법 및 이의 용도
WO2012007570A3 (en) New formulations of 14-epi-analogues of vitamin d

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980114278.9

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09735236

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009735236

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12934286

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 8327/DELNP/2010

Country of ref document: IN